WQ
TAK icon

Wealth Quarterback’s Takeda Pharmaceutical TAK Stock Holding History

Wealth Quarterback’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$3K Buy
129
+3
+2% +$50 ﹤0.01% 681
2021
Q2 		$3K Buy
+126
New +$2.15K ﹤0.01% 713
2020
Q2 		– Sell
-122
Closed -$1.85K – 686
2020
Q1 		$1.85K Hold
122
– – ﹤0.01% 757
2019
Q4 		$2.4K Buy
+122
New +$2.33K ﹤0.01% 739

Other funds holding TAK

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wealth Quarterback's TAK Position: Q3 2021 in Review

Wealth Quarterback increased its Takeda Pharmaceutical (TAK) stake by 2.4% in Q3 2021, buying an estimated $50 and bringing the position to 129 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #681.

Wealth Quarterback first reported a position in TAK in Q4 2019 and has held it in 4 quarters since. 292 funds tracked by Wall St. Rank hold TAK as of Q3 2021.

  • Wealth Quarterback held 129 shares of Takeda Pharmaceutical worth $3K as of Q3 2021.
  • Wealth Quarterback bought 3 Takeda Pharmaceutical shares in Q3 2021, an estimated $50.
  • Takeda Pharmaceutical made up ﹤0.01% of Wealth Quarterback's portfolio in Q3 2021, its #681 holding.
  • Wealth Quarterback first reported a position in Takeda Pharmaceutical in Q4 2019 and has held it in 4 quarters since.
  • 292 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.